San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?
Login to view comments.
Click here to Login
SESSION II - Cardiac Hypertrophy, Amyloid and Other Infiltrative Diseases